Neocolipor
Introduction

Company name: Merial Animal Health Ltd
Address: PO Box 327
Sandringham House
Harlow Business Park
Harlow
Essex CM19 5TG
Telephone: Companion Animals 0870 6000123
Production Animals 0800 592699
Fax: 01279 775888
Email: ukenquiry@merial.com
Website: www.merial.com
Presentation
A suspension for injection. Each 2 ml dose contains at least 2.1 SA.U E. coli recombinant strains F4 (F4ab, F4ac, F4ad); 1.7 SA.U recombinant strain F5; 1.7 SA.U field strain F41; and 1.4 SA.U field strain F6. In addition, NEOCOLIPOR contains aluminium hydroxide as adjuvant and thiomersal (0.2 mg/dose).
Uses
The reduction of neonatal enterotoxicosis of piglets, caused by E. coli strains, expressing the adhesins F4ab (K88ab), F4ac (K88ac), F4ad (K88ad), F5 (K99), F6 (987P) and F41 during the first days of life.
Dosage and administration
A 2 ml dose injected intramuscularly into the neck in the area behind the ear, according to the following schedule:
Primary vaccination
First injection: 5 to 7 weeks before farrowing;
Second injection: 2 weeks before farrowing.
Revaccination
1 injection 2 weeks before each subsequent farrowing.
Contra-indications, warnings, etc
There are no contra-indications.
For animal treatment only.
Vaccinate only healthy animals.
Since the protection of piglets is ensured by colostrum intake, each piglet should ingest a sufficient quantity of colostrum within 6 hours of birth.
Shake the vial vigorously before use.
Use sterile syringe and needles. Administer using aseptic procedures.
Do not administer in conjunction with other medicinal products.
Vaccination may cause slight hyperthermia (less than 1.5°C during a maximum period of 24 hours).
Withdrawal period
Zero days.
Special precautions for disposal of unused product and waste
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with the local requirements.
Operator safety
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or label to the physician.
Wash and disinfect hands after use.
Pharmaceutical precautions
Do not mix with any other vaccine.
Any open bottle must be used within 3 hours.
Store and transport between +2°C and +8°C, protected from light. Do not freeze.
Keep out of the reach and sight of children.
Legal category
POM-V
Packaging Quantities
50 ml/25 dose bottles.
Further information
The vaccine contains several inactivated strains of E. coli expressing the adhesins F4ab, F4ac, F4ad, F5, F6 and F41, which cause neonatal enterotoxicosis in piglets, in aluminium hydroxide adjuvant. In sows and gilts, the vaccine induces the specific seroconversion of vaccinated animals; piglets are immunised by intake of colostrum and milk containing adhesin-specific antibodies.
No undesirable effects have been observed after the administration of twice the recommended dosage.
Marketing authorisation number
EU/2/98/008/001-004.